Literature DB >> 17803962

Cloning of habutobin cDNA and antithrombotic activity of recombinant protein.

Masanori Sunagawa1, Mariko Nakamura, Tadayoshi Kosugi.   

Abstract

The habutobin cDNA was cloned from total RNA extracted from venom glands of Trimeresurus flavoviridis (the habu snake). The conceptual translation of 1539 bp of habutobin cDNA consists of 236 amino acids and its molecular weight is 25.7 kDa. Histidine (His)-tagged recombinant habutobin fusion protein, pET-r-habutobin and AcNPV-r-habutobin, was purified by bacterial system and baculoviral system, respectively. After refolding pET-r-habutobin, there were two protein bands at about 32 kDa and 65 kDa, indicating that habutobin might be produced as a monomer protein and processed to form two concatenated protein. Purified AcNPV-r-habutobin dose-dependently increased fibrin forming activity and inhibited collagen-induced aggregation of rabbit washed platelets. Thus, AcNPV-r-habutobin produced by baculoviral system is very useful for study on structure-function relationship, which is necessary for developing an antithrombotic drug from habutobin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17803962     DOI: 10.1016/j.bbrc.2007.08.103

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Alternative mRNA Splicing in Three Venom Families Underlying a Possible Production of Divergent Venom Proteins of the Habu Snake, Protobothrops flavoviridis.

Authors:  Tomohisa Ogawa; Naoko Oda-Ueda; Kanako Hisata; Hitomi Nakamura; Takahito Chijiwa; Shousaku Hattori; Akiko Isomoto; Haruki Yugeta; Shinichi Yamasaki; Yasuyuki Fukumaki; Motonori Ohno; Noriyuki Satoh; Hiroki Shibata
Journal:  Toxins (Basel)       Date:  2019-10-09       Impact factor: 4.546

2.  Quantitative high-throughput profiling of snake venom gland transcriptomes and proteomes (Ovophis okinavensis and Protobothrops flavoviridis).

Authors:  Steven D Aird; Yutaka Watanabe; Alejandro Villar-Briones; Michael C Roy; Kouki Terada; Alexander S Mikheyev
Journal:  BMC Genomics       Date:  2013-11-14       Impact factor: 3.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.